New Weight-Loss drug SA030 enters first human safety trial
Disease control
Not yet recruiting
This study is the first time the experimental drug SA030 is being tested in people. It aims to check the safety and how the body handles a single dose in 40 overweight or obese adults aged 18 to 55. Participants will be randomly assigned to receive either SA030 or a placebo, and …
Phase: PHASE1 • Sponsor: Suzhou Siran Biotechnology Co.,Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC